Key result
In-silico modeling of swine hearts showed that biomaterial injection therapy in failing hearts increased the number of ventricular fibrillation filaments to 40, compared to 34 in untreated failing hearts and 27 in normal hearts.
Why the study?
While biomaterial injection reduces mechanical wall stress in ischemic HF, its influence on the electrical behavior of treated hearts has not been elucidated.
Does biomaterial injection therapy increase electrophysiological vulnerability and ventricular fibrillation sustainability in computational models of ischemic heart failure?
Does biomaterial injection therapy increase electrophysiological vulnerability and ventricular fibrillation sustainability in computational models of ischemic heart failure?
Absolute Event Rate: 40% vs 34%
In-silico modeling suggests that while biomaterial injection for ischemic heart failure does not worsen repolarization dispersion, it may increase the sustainability of ventricular fibrillation, potentially requiring higher defibrillation energies.
Biomaterial injection is a novel therapy to treat ischemic heart failure (HF) that has shown to reduce remodeling and restore cardiac function in recent preclinical studies. While the effect of biomaterial injection in reducing mechanical wall stress has been recently demonstrated, the influence of biomaterials on the electrical behavior of treated hearts has not been elucidated. In this work, we developed computational models of swine hearts to study the electrophysiological vulnerability associated with biomaterial injection therapy. The propagation of action potentials on realistic biventricular geometries was simulated by numerically solving the monodomain electrophysiology equations on anatomically-detailed models of normal, HF untreated, and HF treated hearts. Heart geometries were constructed from high-resolution magnetic resonance images (MRI) where the healthy, peri-infarcted, infarcted and gel regions were identified, and the orientation of cardiac fibers was informed from diffusion-tensor MRI. Regional restitution properties in each case were evaluated by constructing a probability density function of the action potential duration (APD) at different cycle lengths. A comparative analysis of the ventricular fibrillation (VF) dynamics for every heart was carried out by measuring the number of filaments formed after wave braking. Our results suggest that biomaterial injection therapy does not affect the regional dispersion of repolarization when comparing untreated and treated failing hearts. Further, we found that the treated failing heart is more prone to sustain VF than the normal heart, and is at least as susceptible to sustained VF as the untreated failing heart. Moreover, we show that the main features of VF dynamics in a treated failing heart are not affected by the level of electrical conductivity of the biogel injectates. This work represents a novel proof-of-concept study demonstrating the feasibility of computer simulations of the heart in understanding the arrhythmic behavior in novel therapies for HF.
No takes yet. Share an insight, caveat, or question.
Ramírez et al. (2020) studied Ischemic heart failure (n=3). Biomaterial injection therapy (Algisyl-LVR) vs. Untreated heart failure and normal heart was evaluated on Number of filaments formed during sustained ventricular fibrillation. In-silico modeling of swine hearts showed that biomaterial injection therapy in failing hearts increased the number of ventricular fibrillation filaments to 40, compared to 34 in untreated failing hearts and 27 in normal hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: